Clinical Trial Update: Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BO-112 in basal cell carcinoma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• BO-112 (BO-112)

Snippet

Sponsor: Highlight Therapeutics | Conditions: Basal Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING